Gerwin Van Gerven has over 25 years’ experience advising major corporates and investment firms on competition law. He is widely respected as a highly skilled European competition lawyer, advising on complex competition issues, including on merger control, anti-cartel enforcement, monopolisation cases and other conduct investigations. He represents clients from around the world in proceedings before the European Commission, the European Court of First Instance and the European Court of Justice, courts and competition authorities across. Gerwin’s experience spans many industry sectors, with recent experience in telecoms and information technology, healthcare, consumer goods, retail and energy. He has advised on several of the major merger investigations of the last twenty years, including in around twenty ‘Phase II’- investigations conducted by the European Commission. Gerwin is regarded as one of the leading competition lawyers of his generation. Since many years, he has been ranked consistently amongst the top ten competition lawyers in the world in all major directories.
34
This article has been nominated for the 2023 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. Qualcomm high-profile decision annulled : how the General Court is putting pressure on the Commission to strengthen its demonstration of anticompetitive (...)
295
Background In February 2003, the Commission, with the assistance of the UK’s Office of Fair Trading, conducted a dawn raid at the UK premises of Akzo Nobel and Akcros Chemicals on suspicion of possible anti-competitive practices. During the raid, a dispute arose between the investigation (...)
718
On July 1, 2010, the General Court ruled in an appeal against the European Commission’s first ever finding of abuse of a dominant position by a pharma company. The Court has broadly upheld a Decision the Commission itself characterised as “novel”, but reduced the €60 million fine on (...)
1083
On 6 October, the European Court of Justice (‘ECJ’) issued another “score draw” judgment in the long-running battle of R&D-based pharmaceutical companies to limit parallel trade in medicines across the EU. While the ECJ required the European Commission to conduct an in-depth examination of (...)
274
The European Commission presented its Preliminary Report into the pharmaceutical sector (which runs to 426 pages) at a public hearing on 28 November. The deadline for comments on the Report is 31 January 2009. Click here for a copy of the Report, the Commission’s press release and the (...)
313
On 30 June 2008, the European Commission introduced a new settlement procedure for cartel cases. Under the new procedure, the parties in a cartel investigation may acknowledge their breach of European antitrust law and waive certain procedural rights in exchange for a 10% reduction of the (...)
226
On 26 October 2007, the European Commission initiated a public consultation on a new settlement procedure in cartel cases. The procedure outlined in the Commission’s proposal is aimed at making the Commission’s investigations more efficient. Public comments are due by 21 December 2007 and the (...)
